Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:IMGO Imago BioSciences (IMGO) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Imago BioSciences Stock (NASDAQ:IMGO) 30 days 90 days 365 days Advanced Chart Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Get Imago BioSciences alerts:Sign Up Key Stats Today's Range$36.01▼$36.0150-Day Range$35.78▼$36.0152-Week Range$11.56▼$36.09VolumeN/AAverage Volume171,367 shsMarket Capitalization$1.22 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewImago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.Read More… Receive IMGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imago BioSciences and its competitors with MarketBeat's FREE daily newsletter. Email Address IMGO Stock News HeadlinesRA Capital-backed startup raises $100M; UCB sells China businessAugust 28, 2024 | finance.yahoo.comAvidity Biosciences Stock (NASDAQ:RNA), Analyst Ratings, Price Targets, PredictionsMay 5, 2024 | benzinga.comA brand new opportunity in the stock market revealedToday, I want to unlock a brand new opportunity in the stock market… One that has been able to pay out around 100% in 5 days or less so far on REAL money… It’s all thanks to a hidden force that drives some of the BIGGEST & most repetitive moves in stocks… I call it a Gamma Pocket…December 23, 2024 | DTI (Ad)Imago Theatre aims to find out if time-traveling Neanderthals have answers to climate changeApril 13, 2024 | msn.comMerck: Better Times Ahead On Approvals And OutlookApril 2, 2024 | seekingalpha.comClarus Lifesciences III, L.P.'s Net WorthFebruary 23, 2024 | benzinga.comAnixa Biosciences Inc ANIXDecember 21, 2023 | morningstar.comHarmony Biosciences shares are trading lower after the company reported Q4 financial results.February 23, 2023 | benzinga.comSee More Headlines IMGO Stock Analysis - Frequently Asked Questions How were Imago BioSciences' earnings last quarter? Imago BioSciences, Inc. (NASDAQ:IMGO) issued its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.44) earnings per share for the quarter, missing the consensus estimate of ($0.34) by $0.10. When did Imago BioSciences IPO? Imago BioSciences (IMGO) raised $105 million in an initial public offering (IPO) on Friday, July 16th 2021. The company issued 7,000,000 shares at $14.00-$16.00 per share. What other stocks do shareholders of Imago BioSciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Imago BioSciences investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Advanced Micro Devices (AMD) and Alphabet (GOOG). Company Calendar Last Earnings11/10/2021Today12/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:IMGO CUSIPN/A CIK1623715 Webwww.imagobio.com Phone415-529-5055FaxN/AEmployees27Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-42,310,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-31.85% Return on Assets-30.07% Debt Debt-to-Equity RatioN/A Current Ratio13.15 Quick Ratio13.16 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$6.40 per share Price / Book5.63Miscellaneous Outstanding Shares33,822,000Free Float28,783,000Market Cap$1.22 billion OptionableNot Optionable Beta2.82 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (NASDAQ:IMGO) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imago BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imago BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
